How Azanucleosides Affect Myeloid Cell Fate

The azanucleosides decitabine and azacytidine are used widely in the treatment of myeloid neoplasia and increasingly in the context of combination therapies. Although they were long regarded as being largely interchangeable in their function as hypomethylating agents, the azanucleosides actually hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Stein, Anna, Platzbecker, Uwe, Cross, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406747/
https://www.ncbi.nlm.nih.gov/pubmed/36010665
http://dx.doi.org/10.3390/cells11162589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406747/
https://www.ncbi.nlm.nih.gov/pubmed/36010665
http://dx.doi.org/10.3390/cells11162589

Ejemplares similares